Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus. (2020)

First Author: Fawsitt CG
Attributed to:  Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jval.2019.08.012

PubMed Identifier: 32113623

Publication URI: http://europepmc.org/abstract/MED/32113623

Type: Journal Article/Review

Volume: 23

Parent Publication: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Issue: 2

ISSN: 1098-3015